anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
The use of robotic surgical methods for performing right-sided hemicolectomy has been somewhat controversial, primarily due to concerns related to costs. The purpose of this study is to document the initial robotic right hemicolectomies conducted at our institution and to compare them with a laparoscopic reference group. A significant focus of this study is the detailed analysis of the costs associated with both techniques within the German healthcare system.Surgical and cost-related data for 34 cases each for robotic and laparoscopic right-sided hemicolectomy performed at Nürnberg Hospital were compared. This comparison was conducted through a retrospective single-center case-matched analysis. Cost analysis was carried out following the current guidelines provided by the Institute for the Hospital Remuneration System (InEK) of Germany.The average age of the patient cohort was 70 years, with a male patient proportion of 57.4%. Analysis of perioperative parameters indicated similar outcomes for both surgical techniques. Regarding the incidence of complications of Clavien-Dindo stages III-V (8.8% vs. 17.6%; p = 0.48), a positive trend towards robotic surgery was observed. The cost analysis showed nearly identical total costs for the selected cases in both groups (mean €13,423 vs. €13,424; p = 1.00), with the most significant cost difference noted in surgical (operative) costs (€5,779 vs. €3,521; p < 0.01). The lower costs for laparoscopic cases were primarily due to the reduced material costs (mean €2,657 vs. €702; p < 0.05).In conclusion, both surgical approaches are clinically equivalent, with only minor differences in the total case costs.
Cholinergic circuit defects have been linked to various neurological abnormalities, yet the precise mechanisms underlying the impact of cholinergic signaling on cognitive functions, particularly in the context of neuroinflammation-associated, remain poorly understood. Similarly, while the dopamine receptor (D2R) has been implicated in the pausing of cholinergic interneurons (CIN), its relationship with behavior remains inadequately elucidated. In this study, we aimed to investigate whether D2R plays a role in the regulation of fear and memory in the Hsp60 knockout condition, given the non-canonical involvement of Hsp60 in inflammation. Using a CRE-floxed system, we selectively generated cholinergic neurons specific to Hsp60 knockout mice and subjected them to memory tests. Our results revealed a significant increase in freezing levels during recall and contextual tests in Hsp60-deprived mice. We also observed dysregulation of neurotransmitters and D2R in the hippocampus of Hsp60 knockout mice, along with enhanced impairments in cytokine levels and synaptic protein dysregulations. These changes were accompanied by alterations in PI3K/eIF4E/Jak/ERK/CREB signaling pathways. Notably, D2R agonism via Quinpirole led to a decrease in freezing levels during recall and contextual tests, alongside an increase in IBA-1 expression and improvements in inflammatory response-linked signaling pathways, including JAK/STAT/P38/JNK impairments. Given that these pathways are well-known downstream signaling cascades of D2R, our findings suggest that D2R signaling may contribute to the neuroinflammation induced by Hsp60 deprivation, potentially exacerbating memory impairments.
Suppositories containing calcium lactate are prepared by incorporating calcium lactate or calcium sodium lactate of particle size 0.01 to 0.001 m.m. in a suppository base such as cocoa butter. The finely divided calcium lactate is obtained by (a) grinding calcium lactate in a ball mill and separating finely divided material by air classification, or (b) dehydrating the calcium lactate to contain not more than 1 to 2 molecules of water of hydration e.g. by heating at 100 DEG  C. and 20 to 40 m.m. Hg and grinding in a screen mill.  Preferably not more than 1 part of calcium lactate is used per two parts of suppository base.  Other medicines may be incorporated in the suppository e.g. vitamin D, vitamin C, rutin, epithelial corpuscle extracts (parathyroid gland hormones) or bile acids.
Data categorization is a top concern in medical data to predict and detect illnesses; thus, it is applied in modern healthcare informatics. In modern informatics, machine learning and deep learning models have enjoyed great attention for categorizing medical data and improving illness detection. However, the existing techniques, such as features with high dimensionality, computational complexity, and long-term execution duration, raise fundamental problems. This study presents a novel classification model employing metaheuristic methods to maximize efficient positives on Chronic Kidney Disease diagnosis. The medical data is initially massively pre-processed, where the data is purified with various mechanisms, including missing values resolution, data transformation, and the employment of normalization procedures. The focus of such processes is to leverage the handling of the missing values and prepare the data for deep analysis. We adopt the Binary Grey Wolf Optimization method, a reliable subset selection feature using metaheuristics. This operation is aimed at improving illness prediction accuracy. In the classification step, the model adopts the Extreme Learning Machine with hidden nodes through data optimization to predict the presence of CKD. The complete classifier evaluation employs established measures, including recall, specificity, kappa, F-score, and accuracy, in addition to the feature selection. Data related to the study show that the proposed approach records high levels of accuracy, which is better than the existing models.
The Dil Mil intervention will be implemented during the second and third trimesters of the daughter-in-law's (DILs) pregnancy. It consists of 2 half-day group sessions with DILs, 5 half-day group sessions with mothers-in-law (MILs), and one joint half-day session with DILs and MILs. The sessions are based on participatory learning and action principles and use stories, role-play, and discussion to enhance participants' knowledge, skills, and social support. The DIL-MIL joint session ends in a short celebration (based on a traditional ritual) in which MILs bless their DILs, and the MIL sessions culminate in a ceremony in which MILs' position in the family and community is recognized and celebrated. MILs draw up a family health action plan and take a pledge to reduce gender-based violence (GBV) and protect and promote their family's health.
Coronaviruses cause severe diseases mainly of the respiratory and gastrointestinal tract. The infection of humans with coronaviruses have been known since the sixties to be associated with respiratory tract i.e. common cold-like diseases. Severe Acute Respiratory Syndrome-Corona Virus (SARS-CoV) is a highly aggressive in humans with often fatal outcome. The inventors aim at developing a new prophylactic or preventive therapeutic approach as well as a curative therapeutic approach based on the local delivery of hydroxychloroquine (HCQ) or its metabolite (e.g. Desethylhydroxychloroquine (DHCQ)) into the lung by aerosolization. The present invention relates to a method of treating Severe Acute Respiratory Syndrome-Corona Virus (SARS-CoV) in a patient in need thereof comprising administering to the patient's lungs a therapeutically effective amount of hydroxychloroquine (HCQ) and/or Desethylhydroxychloroquine (DHCQ) by aerosolization.
Methods of treating or preventing chemoresistance or relapse growth of cancer cells are provided. Methods of treating or preventing resistance to tyrosine kinase based chemotherapeutic treatment in hematologic and solid tumors are provided. BCR-ABL drug resistance in chronic myelogenous leukemia (CML) and models for conducting further study on the same are presented. The methods comprise administering a therapeutically effective amount of one or more SIRT1 modulators to the cells or subject in need thereof. The methods may be administered in combination with, prior to or subsequent to chemotherapy or may be administered to counteract the effect of a spontaneous genetic mutation. Methods of using SIRT1 inhibitors to treat or prevent insulin and transferrin-induced resistance are also presented. A novel cell model to study mechanisms of acquired chemoresistance is also provided.
Participants have been in clinical remission and on minimal maintenance therapy for at least 2 years prior to screening. Their primary physicians have planned to discontinue immunosuppression medication in the next year after screening.
<P>PROBLEM TO BE SOLVED: To provide useful inhibitors of JAK, ROCK and Aurora (preferably JAK-3, ROCK and Aurora A) protein kinases.  <P>SOLUTION: A compound of protein kinase, represented by formula (I) is provided. Pharmaceutical compositions containing the compound and methods of using the compositions in treatment of various disorders are provided. The compound and pharmaceutically acceptable compositions thereof are found at present to be effective inhibitors of JAK, ROCK and Aurora protein kinases. In certain embodiments, the compounds are effective as inhibitors of JAK, ROCK and Aurora protein kinases.  <P>COPYRIGHT: (C)2008,JPO&INPIT
A thin film of PRUDOXIN® Cream should be applied four times each day with at least a 3 to 4 hour interval between applications. There are no data to establish the safety and effectiveness of PRUDOXIN® Cream when used for greater than 8 days. Chronic use beyond eight days may result in higher systemic levels and should be avoided. Use of PRUDOXIN® Cream for longer than 8 days may result in an increased likelihood of contact sensitization.

The risk for sedation may increase with greater body surface area application of PRUDOXIN® Cream (See WARNINGS section). Clinical experience has shown that drowsiness is significantly more common in patients applying PRUDOXIN® Cream to over 10% of body surface area; therefore, patients with greater than 10% of body surface area (see WARNINGS section) affected should be particularly cautioned concerning possible drowsiness and other systemic adverse effects of doxepin. If excessive drowsiness occurs, it may be necessary to do one or more of the following: reduce the body surface area treated, reduce the number of applications per day, reduce the amount of cream applied, or discontinue the drug.

Occlusive dressings may increase the absorption of most topical drugs; therefore, occlusive dressings should not be utilized with PRUDOXIN® Cream.
The invention provides application of CXC chemokine receptor 3(CXCR3) as a drug target in screening drugs for treating cough. Our previous studies found that IFN-. gamma.was able to directly cause cough. The invention carries out IFN-gamma nose dropping modeling on the mouse; IFN-gamma was found to cause an enrichment of lymphocytes in peripheral blood and BALF; IFN-gamma was found to cause an increase in the CXC chemokine IP-10, whereas IP-10 has the ability to chemotact lymphocytes; it was found that IFN-. gamma.increased CD3 + IFN‑γ + A T lymphocyte proportion, thereby increasing IFN- γ release; by intraperitoneal injection of the CXCR3 antagonist AMG487,the discovery that the inhibition of CXCR3 target can reduce the proportion of IFN-gamma nasal drip mice peripheral blood and BALF lymphocyte, CD3 + IFN‑γ + The proportion of T lymphocytes is reduced, and the IFN-gamma content in the homogenate of the lung tissue of the mouse is obviously reduced. These results indicate that antagonizing CXCR3 reduces CD3 + IFN‑γ + The proportion of T lymphocytes is reduced, so that IFN-gamma released by the lymphocytes is reduced, and then cough is inhibited, and the CXCR3 or the gene thereof can be used as a potential drug target to be applied to screening or preparing drugs for treating cough.
A 16-week longitudinal intervention study. Males, 30-65 years of age, with at least one component of metabolic syndrome, were randomly assigned to either the intervention group or the control group. At lunch, the intervention group was given 20 g of WGPF per day, which contained 10 g of dietary fiber and an antioxidant capacity of 7,258 ORAC (oxygen radical absorbance capacity) units. Both groups were asked to maintain their regular eating habits and lifestyles. Clinical evaluation, anthropometric measurements and biochemical blood analyses were done at the beginning and the end of the study.

The intervention was carried out at a heavy mining machinery company in Santiago, Chile. All employees were informed about the study and invited to participate. Initially, 47 male workers free of exclusion criteria agreed to participate. The number of participants in each group was chosen based on the variation coefficients in the evolution of total cholesterol in the intervention and in the control group, observed in a previous work (Jiménez, J.P., et al., Effects of grape antioxidant dietary fiber in cardiovascular disease risk factors. Nutrition, 2008. 24(7-8): 646-53).

Statistical analysis: Continuous variables will be shown as mean and standard deviation, while categorical variables as the number of cases and percentage. The student t-test for independent samples and the chi-square test will be used to analyze differences of means and proportions between the two groups, respectively. The student t-test for paired samples and McNemar's test will be used to analyze differences of means and proportions within each group. When appropriate, the Wilcoxon signed rank-sum test will be used to compare paired medians. All p values will be two-tailed and a value \<0.05 will be considered to be statistically significant. Data processing and statistical analyses will be done with the SAS statistical software package version 9.1 for Windows.
Our objective is to describe our approach for a case of subacute on top of chronic thromboembolic disease and highlight operative learning points. Prior to incision, appropriate monitoring equipment, including an arterial line, Swan-Ganz catheter, brain saturation monitor and bispectral index monitor, is placed for proper management of haemodynamics. Sternotomy was performed, and the ascending aorta was cannulated, followed by bicaval cannulation for venous drainage. The patient was cooled to deep hypothermia. Once target temperature was achieved, circulatory arrest commenced. The left pulmonary artery was opened and the subacute component was removed without disrupting the plane of the chronic thromboembolic disease. An endarterectomy plane was then created proximally and dissected into the distal segmental/subsegmental branches. Once the endarterectomy was completed, the left pulmonary artery was closed. Circulation was resumed for end-organ perfusion. Once the right pulmonary artery was ready for dissection, circulatory arrest was restarted. Similarly to the left side, the subacute component was removed without disrupting the plane of the chronic thromboembolic disease. An endarterectomy plane was then created proximally and dissected into the distal segmental/subsegmental branches. Circulation was then resumed. Once rewarmed to 35.5°C, the patient was decannulated and the sternum was closed.
BACKGROUND: Several studies have demonstrated that females have a higher risk of arrhythmia recurrence after pulmonary vein (PV) isolation for atrial fibrillation (AF). There are limited data on sex-based differences in PV reconnection rates at repeat ablation. We aimed to investigate sex-based differences in electrophysiological findings and atrial arrhythmia recurrence after repeat AF ablation METHODS: We conducted a retrospective study of 161 consecutive patients (32% female, age 65 ± 10 years) who underwent repeat AF ablation after index PV isolation between 2010 and 2022. Demographics, procedural characteristics and follow-up data were collected. Recurrent atrial tachycardia (AT)/AF was defined as any atrial arrhythmia ≥30 s in duration.
RESULTS: Compared to males, females tended to be older and had a significantly higher prevalence of prior valve surgery (10 vs. 2%; P = .03). At repeat ablation, PV reconnection was found in 119 (74%) patients. Males were more likely to have PV reconnection at repeat ablation compared to females (81 vs. 59%; P = .004). Excluding repeat PV isolation, there were no significant differences in adjunctive ablation strategies performed at repeat ablation between females and males. During follow-up, there were no significant differences in freedom from AT/AF recurrence between females and males after repeat ablation (63 vs. 59% at 2 years, respectively; P = .48).
CONCLUSIONS: After initial PV isolation, significantly fewer females have evidence of PV reconnection at the time of repeat ablation for recurrent AF. Despite this difference, long-term freedom from AT/AF was similar between females and males after repeat ablation.
The title of the invention of the present application is a catheter assembly with monitoring function. The present invention provides a catheter assembly or other elongate tubular device for establishing a blood vessel or other passageway within the body of a patient. The catheter assembly is equipped with one or more sensors that allow monitoring of one or more physiological aspects of the patient or physical aspects of the catheter assembly itself when the catheter assembly is disposed within the patient. Such aspects include central venous pressure, body temperature, ECG cardiac signals, oxygen content, ultrasound data, glucose, and the like. The catheter assembly has functionality for wirelessly transmitting or otherwise forwarding data related to the detected physiological parameter to another location, such as a patient electronic medical record, a smart phone or other mobile device, a nurse station, or the like. Catheter assemblies configured to detect the catheter flush frequency, flush quality, and the like are also disclosed.
BACKGROUND: Patients with a personal or family history of cancer may have elevated risk of developing future cancers, which often remains unrecognized due to lapses in screening. This pilot study assessed the usability and clinical outcomes of a cancer risk stratification tool in a gynecologic oncology clinic.
METHODS: New gynecologic oncology patients were prompted to complete a commercially developed personal and family history-based risk stratification tool to assess eligibility for genetic testing using National Comprehensive Cancer Network criteria and estimated lifetime breast cancer risk using the Tyrer-Cuzick model. After use of the risk stratification tool, usability was assessed via completion rate and the System Usability Scale, and health literacy was assessed using the BRIEF Health Literacy Screening Tool.
RESULTS: 130 patients were prompted to complete the risk stratification tool; 93 (72%) completed the tool. Race and ethnicity and insurance type were not associated with tool completion. The median System Usability Scale score was 83 out of 100 (interquartile range, 60-95). Health literacy positively correlated with perceived usability. Public insurance and race or ethnicity other than non-Hispanic White was associated with lower perceived usability. Sixty (65%) patients met eligibility criteria for genetic testing, and 21 (38% of 56 eligible patients) were candidates for enhanced breast cancer screening based on an estimated lifetime breast cancer risk of ≥20%.
CONCLUSIONS: A majority of patients completed the digital cancer risk stratification tool. Older age, lower health literacy, public insurance, and race or ethnicity other than non-Hispanic White were associated with lower perceived tool usability.
Aerobic physical exercise was applied during 3 months, 3x/week on women with type 2 diabetic. The evaluation occurred before and after exercise in the same (and only) group, considering that this is a quasi-experimental study.
Driver drowsiness is a significant factor in road accidents. Thermal imaging has emerged as an effective tool for detecting drowsiness by enabling the analysis of facial thermal patterns. However, it is not clear which facial areas are most affected and correlate most strongly with drowsiness. This study examines the variations and importance of various facial areas and proposes an approach for detecting driver drowsiness. Twenty participants underwent tests in a driving simulator, and temperature changes in various facial regions were measured. The random forest method was employed to evaluate the importance of each facial region. The results revealed that temperature changes in the nasal area exhibited the highest value, while the eyes had the most correlated changes with drowsiness. Furthermore, drowsiness was classified with an accuracy of 88 % utilizing thermal variations in the facial region identified as the most important regions by the random forest feature importance model. These findings provide a comprehensive overview of facial thermal imaging for detecting driver drowsiness and introduce eye temperature as a novel and effective measure for investigating cognitive activities.
PURPOSE: A composition for suppressing hair loss or promoting hair growth is provided to promote proliferation and migration of dermal papilla cells and expression of growth factors, thereby being used as a material for drugs or cosmetic products for suppressing hair loss and treating alopecia. CONSTITUTION: A composition for preventing hair loss or promoting hair growth contains vimentin proteins as active ingredients. The vimentin proteins are derived from a mammal. The mammal is human. The vimentin protein is denoted by sequence number 1. The composition contains fusion proteins containing vimentin proteins and a protein transduction domain as active ingredients.
PROBLEM TO BE SOLVED: To obtain the subject compound effective for inhibiting the skin exuberance and growth of tumor cell. and useful for the treatment of hypertrophic dermatosis such as psoriasis, neoplastic diseases such as leukemia, sebaceous diseases such as acne and seborrheic dermatitis, etc. SOLUTION: This compound is expressed by the formula I (R is hydroxy and both R' and R'' are H at the same time or together form =CH2 or R is H or fluorine and R' and R" together form =CH2 ). Most preferable compound is 1,25-dihydroxy-16,22S,23-trienecholecalciferol or 1,25-dihydroxy-16,22R,23- trienecholecalciferol. The compound of the formula I can be produced e.g. by using a compound of the formula II (R<4> and R<6> are each a lower alkyl; R<5> is a lower alkyl, an aryl, etc.) as a starting substance and eliminating a silyl- protecting group from a silylated diol or trial corresponding to the formula I in the final stage.
Group 3: intravenous remifentanil and paravertebral SF. During the maintenance of anesthesia, a continuous intravenous infusion of remifentanil at a rate of 0.1 mg/kg/min until the end of surgery and an infusion of 0.9% SF through the intraoperative paravertebral catheter at a rate of 0.1 ml / kg / h.
Patients presented with non-keratinizing NPC and stage T3-4N1M0/TxN2-3M0 are randomly assigned to receive induction chemotherapy (docetaxel+cisplatin+fluorouracil) plus concurrent chemoradiotherapy (investigational arm) or concurrent chemoradiotherapy (control arm). Patients in both arms receive radical radiotherapy, and cisplatin (100mg/m2) every three weeks for three cycles during radiotherapy. Patients in the investigational arm receive docetaxel(60mg/m2 on day 1), cisplatin (60mg/m2 on day 1) and fluorouracil (600mg/m2 on Days 1 to 5) every three weeks for three cycles before the radiotherapy. Patients are stratified according to the treatment centers and stage. The primary end point is failure-free survival (FFS). Secondary end points include overall survival (OS), distant failure-free survival (D-FFS), locoregional failure-free survival (LR-FFS), initial response rates after treatments and toxic effects. All efficacy analyses are conducted in the intention-to-treat population; the safety population include only patients who receive their randomly assigned treatment.